Einat Galamidi
CIK: 0002076463
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENLV
Enlivex Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Galamidi Einat
Galamidi Einat (SEC CIK 0002076463) files insider reports with the SEC as Chief Medical Officer of Enlivex Ltd. (ENLV).
Signal8 holds 1 ownership filing by Galamidi Einat, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Galamidi Einat's filings is in NESS ZIONA.
Other insiders filing for Enlivex Ltd. (ENLV)
- Hershkovitz Oren, Chief Executive Officer
- Shlosberger Shachar, Chief Financial Officer
- Hart Gili, Director
- NOVIK SHAI A, Director
- Pomerantz Roger, Director
- Havron Avraham, Director